Clinical Trial Update: Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating L-citrulline supplementation in overweight individuals with late-onset asthma phenotypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Obesity

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Asthma, Obesity | Phase 2 | Status: RECRUITING